Charles River Q1 revenue $1.03B, +12.6% YoY; raises organic growth guidance to 5.0-7.5%

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

2023-Q1 EPS reported $2.01 revenue$1,029,373,000

GAAP EPS $2.01 (+11% YoY); non-GAAP EPS $2.78 (+1.1% YoY); net income $103.1M.
DSA segment revenue $662.4M (+23.6% organic); non-GAAP operating margin 29.0%.
Manufacturing segment revenue $167.3M (-1.8% organic); non-GAAP operating margin 13.7%.
2023 guidance narrowed: organic revenue growth 5.0-7.5% (prior 4.5-7.5%); non-GAAP EPS $9.90-$10.90.
Management cites strong DSA demand but warns Cambodian NHP supply constraints will affect H2.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported the first quarter ended April 1, 2023 results: revenue $1.03 billion, net income $103.1 million, EPS $2.01. Guidance reaffirmed.

Period: the first quarter ended April 1, 2023
Revenue: $1.03 billion
Net income: $103.1 million
EPS: $2.01
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Charles River Laboratories Announces First-Quarter 2023 Results – First-Quarter Revenue of $1.03 Billion – – First-Quarter GAAP Earnings per Share of $2.01 and Non-GAAP Earnings per Share of $2.78 – – Updates 2023 Guidance –

View on SEC.gov

39 earnings releases filed in the last 30 days. Browse all earnings releases →

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filing history →

Source: SEC EDGAR

accession 0001157523-23-000819

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.